Medication info
Beazal Tablet 5/50 mg

Beazal Tablet 5/50 mg

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.944mg / 1 tabletLosartan Potassium›50mg / 1 tablet
Manufacturer / importer
Daewoong Bio Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201502673 · Approved 2015.04.30 · Insurance code 694001050

Summary

Main use
Treatment of essential hypertension; initial treatment of stage 2 hypertension
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or losartan) before starting this medicine. However, if blood pressure is not controlled with monotherapy using an individual component, switching directly to this medicine may be considered as follows. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience. Before using this medicine as initial therapy in patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of reaching the treatment goal with combination therapy compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced intravascular volume: Use of this medicine is not recommended in the small number of patients with reduced intravascular volume (e.g., patients receiving treatment with high doses of diuretics). (See Section 1. Warnings under Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Elderly patients: In elderly patients aged 75 years or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.
Child dose
○ Pediatric patients: Use of this medicine is not recommended in pediatric patients aged 18 years or younger because its safety and efficacy have not been established.

Ingredients

Manufacturer
Daewoong Bio Co., Ltd.

Efficacy & effects

Treatment of essential hypertension; initial treatment of stage 2 hypertension

  • Essential hypertension
  • stage 2 hypertension
View approved original text

This medication is used for patients with essential hypertension who have difficulty controlling blood pressure with monotherapy, and is also used as an initial therapy in combination to help stage 2 hypertension patients reach their target blood pressure. It effectively controls blood pressure, thereby reducing the risk of cardiovascular diseases and improving overall health.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or losartan) before starting this medicine. However, if blood pressure is not controlled with monotherapy using an individual component, switching directly to this medicine may be considered as follows. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience. Before using this medicine as initial therapy in patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of reaching the treatment goal with combination therapy compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced intravascular volume: Use of this medicine is not recommended in the small number of patients with reduced intravascular volume (e.g., patients receiving treatment with high doses of diuretics). (See Section 1. Warnings under Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Elderly patients: In elderly patients aged 75 years or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.

Child dose

○ Pediatric patients: Use of this medicine is not recommended in pediatric patients aged 18 years or younger because its safety and efficacy have not been established.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. Taking this medication during pregnancy may result in severe side effects such as hypotension and renal failure in newborns. It is safer for women with the possibility of pregnancy to avoid using this medication, and those who are breastfeeding should also refrain from taking it. Patients with low blood volume or those on diuretics should be cautious as their blood pressure may drop too low when starting this medication. Patients allergic to any of the components in this medication, or those with severe liver or heart dysfunction, should not take it. Symptoms such as dizziness or drowsiness may occur during the treatment of hypertension; therefore, driving and operating dangerous machinery should be avoided. The effect of this medication may be enhanced when taken with other antihypertensives, so it should be taken under medical advice. Overdosage may lead to severe hypotension or cardiac issues, so the prescribed dosage must be strictly followed. While taking this medication, side effects such as dizziness, headache, swelling, dyspepsia, and skin rash may occur, and a doctor should be consulted if symptoms are severe. Special care should be taken when using this medication in patients with decreased kidney function or hyperkalemia, as blood potassium levels should be closely monitored. Pregnant or lactating women, children and the elderly must take this medication with special caution and consult sufficiently with healthcare professionals before use.

Side effects

  • Hypotension
  • neonatal craniosynostosis
  • anuria
  • renal failure
  • oligohydramnios
  • fetal limb hypoplasia
  • craniofacial malformation
  • pulmonary hypoplasia
  • prematurity
  • intrauterine growth restriction
Show 171 more
  • patent ductus arteriosus
  • dizziness
  • headache
  • drowsiness
  • cerebral infarction
  • weakness
  • chest discomfort
  • chest pain
  • early satiety
  • peripheral edema
  • pitting edema
  • abdominal discomfort
  • indigestion
  • nausea
  • gastroesophageal reflux disease
  • constipation
  • pruritus
  • urticaria
  • palpitations
  • flushing
  • orthostatic hypotension
  • facial flushing
  • dyspnea
  • cough
  • conjunctival injection
  • increased urinary frequency
  • fatigue
  • edema
  • dizziness
  • abdominal pain
  • nausea
  • weakness
  • lethargy
  • pain
  • weight gain
  • weight loss
  • hypotension
  • vasculitis
  • hypertonia
  • sensory loss
  • paresthesia
  • peripheral neuropathy
  • syncope
  • taste disturbance
  • tremor
  • erectile dysfunction
  • gynecomastia
  • changes in bowel habits
  • dry mouth
  • gastritis
  • gingival hyperplasia
  • pancreatitis
  • vomiting
  • hyperglycemia
  • insomnia
  • mood changes
  • cough
  • rhinitis
  • hair loss
  • increased sweating
  • purpura
  • skin discoloration
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased urinary frequency
  • urinary disturbances
  • nocturia
  • hepatitis
  • jaundice
  • elevation of liver enzymes
  • pruritus
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • hypotensive effect
  • sinoatrial block
  • atrioventricular block
  • precordial pain
  • diarrhea
  • loose stools
  • skin rash
  • papular rash
  • malaise
  • warmth
  • impaired glucose tolerance
  • weakness
  • muscle cramps
  • low back pain
  • limb pain
  • congestion
  • upper respiratory infection
  • sinusitis
  • sinus disorders
  • pharyngitis
  • myalgia
  • swelling
  • decreased appetite
  • toothache
  • flatulence
  • gastritis
  • anemia
  • gout
  • upper limb pain
  • hip pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • rigidity
  • arthralgia
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorders
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory decrease
  • decreased libido
  • memory impairment
  • migraine
  • hyperesthesia
  • panic disorder
  • sleep disorders
  • bronchitis
  • pharyngeal discomfort
  • nasal bleeding
  • rhinitis
  • respiratory congestion
  • dermatitis
  • skin dryness
  • petechial hemorrhage
  • erythema
  • photosensitivity
  • rash
  • sweating
  • urticaria
  • blurred vision
  • burning sensation in the eyes
  • ocular pain
  • conjunctivitis
  • dysgeusia
  • tinnitus
  • decreased vision
  • urethral infection
  • angioedema
  • vasculitis
  • anaphylactic reaction
  • liver dysfunction
  • intestinal vascular edema
  • lethargy
  • thrombocytopenia
  • rhabdomyolysis
  • taste disturbance
  • dry cough
  • erythematous skin lesion
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • increased serum creatinine
  • elevated liver enzymes
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • anaphylactoid syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a sealed container. It is advisable to maintain a storage temperature between 1 to 30 degrees Celsius. This will help to retain the efficacy and safety of the medication for a longer period.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.